Cargando…

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma

Lung adenocarcinoma (LUAD) accounts for a frequently seen non-small cell lung cancer (NSCLC) histological subtype, and it is associated with dismal prognostic outcome. However, the benefits of traditional treatment are still limited, and the efficacies of immunotherapy are quite different. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhonghui, Sun, Dan, Zhu, Qing, Liu, Xinmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806236/ https://www.ncbi.nlm.nih.gov/pubmed/33870858 http://dx.doi.org/10.1080/21655979.2021.1911211

Ejemplares similares

Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma
por: Wang, Yanyun, et al.
Publicado: (2020)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Follistatin Is a Novel Biomarker for Lung Adenocarcinoma in Humans
por: Chen, Fangfang, et al.
Publicado: (2014)

Construction of an immune-related lncRNA pairs model to predict prognosis and immune landscape of lung adenocarcinoma patients
por: Liu, Junhui, et al.
Publicado: (2021)

A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Cheng, Yuanjun, et al.
Publicado: (2022)

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
por: Shi, Xiaoshun, et al.
Publicado: (2020)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors
por: Wu, Yanping, et al.
Publicado: (2020)

Integrated Analysis of Cell Cycle–Related and Immunity-Related Biomarker Signatures to Improve the Prognosis Prediction of Lung Adenocarcinoma
por: Chen, Fangyu, et al.
Publicado: (2021)

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

Development and validation of an immune‐related gene signature for prognosis in Lung adenocarcinoma
por: Guo, Zehuai, et al.
Publicado: (2023)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
por: Sun, Hao, et al.
Publicado: (2020)

Subtype Classification, Immune Infiltration, and Prognosis Analysis of Lung Adenocarcinoma Based on Pyroptosis-Related Genes
por: Liu, Qi, et al.
Publicado: (2022)

Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma
por: Huo, Chen, et al.
Publicado: (2020)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

A novel tetraspanin-related gene signature for predicting prognosis and immune invasion status of lung adenocarcinoma
por: Zhu, Yindong, et al.
Publicado: (2023)

STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis
por: Zhang, Wen-Di, et al.
Publicado: (2023)

Spondin2 is a new prognostic biomarker for lung adenocarcinoma
por: Yuan, Xiaopeng, et al.
Publicado: (2017)

Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes
por: Zhou, Ting, et al.
Publicado: (2021)

A novel immune-related long non-coding RNAs risk model for prognosis assessment of lung adenocarcinoma
por: Lu, Songmei, et al.
Publicado: (2021)

Immune-related biomarker risk score predicts prognosis in prostate cancer
por: Liu, Zezhen, et al.
Publicado: (2020)

Prognosis-related autophagy genes in female lung adenocarcinoma
por: Liu, Zhongxiang, et al.
Publicado: (2022)

Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
por: Fan, Zhengyang, et al.
Publicado: (2023)

A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Qing-Hua, et al.
Publicado: (2023)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

TRIM28 is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma
por: Liu, Jie, et al.
Publicado: (2020)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

Surgery versus radiotherapy in octogenarians with stage Ia non‑small cell lung cancer: propensity score matching analysis of the SEER database
por: Ni, Lianfang, et al.
Publicado: (2022)

CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma
por: Sun, Longhua, et al.
Publicado: (2015)

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients
por: Shen, Edward, et al.
Publicado: (2021)

Transcriptome analysis of adipocytokines and their-related LncRNAs in lung adenocarcinoma revealing the association with prognosis, immune infiltration, and metabolic characteristics
por: Ren, Jie, et al.
Publicado: (2022)

CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
por: Meng, Chuang, et al.
Publicado: (2022)

A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Tang, Xiaolong, et al.
Publicado: (2022)

Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma
por: Cai, Jinlian, et al.
Publicado: (2020)

Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
por: Wang, Fangwei, et al.
Publicado: (2022)

Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vr03pkjhmq9857i281b58bhf4r